A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The hope of this study is to gather data and information about the tolerability and
effectiveness of Lexiva versus Sustiva in patients who have have been generally
underrepresented in clinical trials.